| dc.contributor.author | Singh, A K | |
| dc.contributor.author | Yadav, A B | |
| dc.contributor.author | Garg, Rajiv | |
| dc.contributor.author | Misra, Amit | |
| dc.date.accessioned | 2014-07-31T10:01:28Z | |
| dc.date.available | 2014-07-31T10:01:28Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Pharmacogenomics, 2014,15(4), 497-508 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/1324 | |
| dc.description.abstract | Aims: To investigate survival of Mycobacterium tuberculosis in primary macrophages with single nucleotide polymorphisms (SNPs) affecting cytokine secretion, under treatment with drugs in solution or microparticles. Materials & Methods: Volunteers were typed for tumor necrosis factor (TNF) (-308 G/A), interleukin (IL)-10 (-1082 A/G) and IL-4 (-590 C/T). Monocyte-derived macrophages (MDMs) were infected in vitro. Cytokine secretion and survival of intracellular bacilli were estimated. Results: IL-10 AG associated with high secretion in uninfected and infected MDMs (P<0.05) and was reduced more effectively by microparticles than drugs, irrespective of genotype (P<0.05). Differences were observed between IL-4 secretion by CC and TT (P<0.1). Bacteria proliferated more in MDMs from volunteers with higher IL-4 (P<0.05). Microparticles showed higher efficacy (P<0.05) than drugs. Conclusions: IL-4 and IL-10 SNPs affect the ability of macrophages to counter infection with M tuberculosis. Microparticles elicit favourable macrophage cytokines regardless of SNPs. | en |
| dc.format.extent | 251062 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | CSIR-CDRI Communication No.8573 | en |
| dc.subject | SNPs | en |
| dc.subject | Inhalable Microparticles | en |
| dc.subject | Isoniazid, Rifabutin | en |
| dc.subject | Tumor Necrosis Factor | en |
| dc.subject | Interleukin 10 | en |
| dc.subject | Interleukin 4 | en |
| dc.title | Single-nucleotide polymorphic macrophage cytokine regulation by Mycobacterium tuberculosis and drug treatment | en |
| dc.type | Article | en |